gusperimus has been researched along with Colitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CY; Joh, JW; Jung, DY; Kim, EY; Kim, MS; Kim, SJ; Kwon, CH; Lee, J; Park, HJ | 1 |
1 other study(ies) available for gusperimus and Colitis
Article | Year |
---|---|
15-deoxyspergualin prevents mucosal injury by inhibiting production of TNF-alpha and down-regulating expression of MD-1 in a murine model of TNBS-induced colitis.
Topics: Administration, Rectal; Animals; Antigens, CD19; Antigens, Surface; Apoptosis; B-Lymphocytes; Cell Proliferation; Colitis; Colon; Disease Models, Animal; Down-Regulation; Female; Guanidines; Immunosuppressive Agents; Injections, Intraperitoneal; Interferon-gamma; Intestinal Mucosa; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Toll-Like Receptors; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2007 |